Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.


The biological actions of estrogen are manifest through two genetically distinct estrogen receptors (ER alpha and ER beta) that display nonidentical expression patterns in target tissues. The phenotypic alterations in response to estrogens in mice disrupted for either or both of these receptors are not identical, suggesting that each subtype plays a unique… (More)


  • Presentations referencing similar topics